CSR Program: Drugs for Neglected Disease Initiative | Takeda Pharmaceuticals
Equipping facilities with safe, effective tools, training primary health workers and supporting community awareness and behaviors
Over one billion people, including 500 million children, are affected by neglected tropical diseases (NTDs), a group of diseases that disproportionally prevail in tropical and subtropical countries. DNDi targets five NTDs: sleeping sickness, Chagas disease, leishmaniasis, onchocerciasis and mycetoma. These are characterized by significant morbidity and/or mortality and have been prioritized due to the current limited availability and accessibility of effective diagnostic and treatment.